ATE543488T1 - Medizinische vorrichtungen, bei denen neuepolymere verwendet werden - Google Patents

Medizinische vorrichtungen, bei denen neuepolymere verwendet werden

Info

Publication number
ATE543488T1
ATE543488T1 AT03786836T AT03786836T ATE543488T1 AT E543488 T1 ATE543488 T1 AT E543488T1 AT 03786836 T AT03786836 T AT 03786836T AT 03786836 T AT03786836 T AT 03786836T AT E543488 T1 ATE543488 T1 AT E543488T1
Authority
AT
Austria
Prior art keywords
medical devices
polymers
new polymers
polymer
active agent
Prior art date
Application number
AT03786836T
Other languages
English (en)
Inventor
Karen Giroux
Original Assignee
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rutgers filed Critical Univ Rutgers
Application granted granted Critical
Publication of ATE543488T1 publication Critical patent/ATE543488T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6957—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a device or a kit, e.g. stents or microdevices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyesters Or Polycarbonates (AREA)
AT03786836T 2002-11-18 2003-11-18 Medizinische vorrichtungen, bei denen neuepolymere verwendet werden ATE543488T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42747602P 2002-11-18 2002-11-18
PCT/US2003/036925 WO2004045549A2 (en) 2002-11-18 2003-11-18 Medical devices employing novel polymers

Publications (1)

Publication Number Publication Date
ATE543488T1 true ATE543488T1 (de) 2012-02-15

Family

ID=32326542

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03786836T ATE543488T1 (de) 2002-11-18 2003-11-18 Medizinische vorrichtungen, bei denen neuepolymere verwendet werden

Country Status (10)

Country Link
EP (1) EP1572154B1 (de)
JP (1) JP4987232B2 (de)
KR (1) KR20050086736A (de)
CN (1) CN1735404A (de)
AT (1) ATE543488T1 (de)
AU (1) AU2003295635A1 (de)
CA (1) CA2506319C (de)
DK (1) DK1572154T3 (de)
ES (1) ES2377827T3 (de)
WO (1) WO2004045549A2 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985415B2 (en) 1997-09-10 2011-07-26 Rutgers, The State University Of New Jersey Medical devices employing novel polymers
CA2417389C (en) 2000-07-27 2012-05-29 Rutgers, The State University Therapeutic polyesters and polyamides
US7169404B2 (en) * 2003-07-30 2007-01-30 Advanced Cardiovasular Systems, Inc. Biologically absorbable coatings for implantable devices and methods for fabricating the same
US20050148512A1 (en) 2003-11-10 2005-07-07 Angiotech International Ag Medical implants and fibrosis-inducing agents
WO2006032202A1 (en) * 2004-09-21 2006-03-30 Shandong Luye Pharmaceutical Co., Ltd. Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof
US20060253079A1 (en) * 2005-04-25 2006-11-09 Mcdonough Justin Stratum corneum piercing device
US8263060B2 (en) 2005-05-23 2012-09-11 Rutgers, The State University Of New Jersey Fast degrading polymers
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
JP5756588B2 (ja) 2005-07-15 2015-07-29 ミセル テクノロジーズ、インコーポレイテッド 制御されたモルホロジーの薬剤粉末を含むポリマーコーティング
JP5217026B2 (ja) * 2006-02-28 2013-06-19 株式会社日本ステントテクノロジー ステント及びその製造方法
US20070225472A1 (en) 2006-03-23 2007-09-27 Varshney Sunil K Polyanhydride polymers and their uses in biomedical devices
CN101472914B (zh) 2006-04-20 2015-05-20 詹森药业有限公司 C-fms激酶抑制剂
US8697716B2 (en) 2006-04-20 2014-04-15 Janssen Pharmaceutica Nv Method of inhibiting C-KIT kinase
CA2650590C (en) 2006-04-26 2018-04-03 Micell Technologies, Inc. Coatings containing multiple drugs
CA2654376A1 (en) 2006-06-06 2007-12-13 Rutgers, The State University Of New Jersey Iodinated polymers
CA2656112A1 (en) * 2006-06-30 2008-05-08 Hanje Chen Bioresponsive polymers
WO2008034019A2 (en) 2006-09-13 2008-03-20 Polymerix Corporation Active agents and their oligomers and polymers
CA2667228C (en) 2006-10-23 2015-07-14 Micell Technologies, Inc. Holder for electrically charging a substrate during coating
JP2010507668A (ja) * 2006-10-23 2010-03-11 バイオアブソーバブル セラピューティクス， インコーポレイテッド 治療担体を有する薬物放出組成物
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
CN101711137B (zh) * 2007-01-08 2014-10-22 米歇尔技术公司 具有可生物降解层的支架
US20080243241A1 (en) * 2007-03-28 2008-10-02 Zhao Jonathon Z Short term sustained drug-delivery system for implantable medical devices and method of making the same
EP2146701B1 (de) 2007-04-12 2013-10-16 Rutgers, The State University of New Jersey Biologisch abbaubare polyanhydride mit natürlichen bioaktiven molekülen
SG192523A1 (en) 2008-04-17 2013-08-30 Micell Technologies Inc Stents having bioabsorbable layers
US8916188B2 (en) 2008-04-18 2014-12-23 Abbott Cardiovascular Systems Inc. Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block
JP2011528275A (ja) 2008-07-17 2011-11-17 ミセル テクノロジーズ，インク． 薬物送達医療デバイス
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
WO2010120552A2 (en) 2009-04-01 2010-10-21 Micell Technologies, Inc. Coated stents
WO2010121187A2 (en) 2009-04-17 2010-10-21 Micell Techologies, Inc. Stents having controlled elution
US8221396B2 (en) 2009-08-27 2012-07-17 Silver Bullet Therapeutics, Inc. Bone implants for the treatment of infection
US10265435B2 (en) 2009-08-27 2019-04-23 Silver Bullet Therapeutics, Inc. Bone implant and systems and coatings for the controllable release of antimicrobial metal ions
US9821094B2 (en) 2014-06-11 2017-11-21 Silver Bullet Therapeutics, Inc. Coatings for the controllable release of antimicrobial metal ions
US9114197B1 (en) 2014-06-11 2015-08-25 Silver Bullett Therapeutics, Inc. Coatings for the controllable release of antimicrobial metal ions
US8927004B1 (en) 2014-06-11 2015-01-06 Silver Bullet Therapeutics, Inc. Bioabsorbable substrates and systems that controllably release antimicrobial metal ions
EP2531140B1 (de) 2010-02-02 2017-11-01 Micell Technologies, Inc. Stent und stenteinsatzsystem mit verbesserter einsetzbarkeit
EP2560576B1 (de) 2010-04-22 2018-07-18 Micell Technologies, Inc. Stents und andere vorrichtungen mit beschichtung durch eine extrazelluläre matrix
WO2012009684A2 (en) 2010-07-16 2012-01-19 Micell Technologies, Inc. Drug delivery medical device
EP3037066B1 (de) 2010-11-12 2017-08-16 Silver Bullet Therapeutics Inc. Knochenimplantat zur kontrollierten freisetzung von silber
WO2013012689A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
US9144579B2 (en) 2012-08-17 2015-09-29 Rutgers, The State University Of New Jersey Polyesters and methods of use thereof
US20140120057A1 (en) 2012-10-25 2014-05-01 Rutgers, The State University Of New Jersey Polymers and methods thereof for wound healing
JP2013066727A (ja) * 2012-10-30 2013-04-18 Japan Stent Technology Co Ltd ステントの製造方法
EP2967803B1 (de) 2013-03-12 2023-12-27 Micell Technologies, Inc. Bioabsorbierbare biomedizinische implantate
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair
EP2996629B1 (de) 2013-05-15 2021-09-22 Micell Technologies, Inc. Bioabsorbierbare biomedizinische implantate
US9862672B2 (en) 2013-05-29 2018-01-09 Rutgers, The State University Of New Jersey Antioxidant-based poly(anhydride-esters)
US9452242B2 (en) 2014-06-11 2016-09-27 Silver Bullet Therapeutics, Inc. Enhancement of antimicrobial silver, silver coatings, or silver platings
WO2015191742A1 (en) 2014-06-13 2015-12-17 Rutgers, The State University Of New Jersey Process and intermediates for preparing poly(anhydride-esters)
WO2016164898A1 (en) 2015-04-10 2016-10-13 Rutgers, The State University Of New Jersey Kojic acid polymers
MX2019013346A (es) * 2017-05-11 2020-01-20 Alpha Tau Medical Ltd Recubrimientos polimericos para dispositivos de braquiterapia.
KR102715288B1 (ko) 2018-04-02 2024-10-11 알파 타우 메디컬 리미티드 방사성 핵종의 제어된 방출
AU2021400142A1 (en) 2020-12-16 2023-06-22 Alpha Tau Medical Ltd. Diffusing alpha-emitters radiation therapy with enhanced beta treatment
CN115137747B (zh) * 2022-06-27 2023-09-01 中山大学孙逸仙纪念医院 多聚水杨酸在治疗急性心肌梗死中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
JPH06172426A (ja) * 1992-12-08 1994-06-21 Shin Etsu Chem Co Ltd 側鎖にアセチルサリチル酸基を有する重合体
JP3091366B2 (ja) * 1993-06-25 2000-09-25 信越化学工業株式会社 アセチルサリチル酸ビニル−ビニルアルコール系共重合体
US6087479A (en) * 1993-09-17 2000-07-11 Nitromed, Inc. Localized use of nitric oxide-adducts to prevent internal tissue damage
US5637113A (en) * 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
US5877263A (en) * 1996-11-25 1999-03-02 Meadox Medicals, Inc. Process for preparing polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents
US6395021B1 (en) * 1997-02-26 2002-05-28 Applied Medical Resources Corporation Ureteral stent system apparatus and method
JP2000513988A (ja) * 1997-06-18 2000-10-24 ボストン サイエンティフィック リミテッド 抗血栓性コーティングのためのポリカーボネート−ポリウレタン分散液
KR20010023852A (ko) * 1997-09-10 2001-03-26 루트거스, 주립대학교 치료적으로 유용한 분해 산물을 갖는 폴리안하이드라이드
US7662409B2 (en) * 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US6299980B1 (en) * 1998-09-29 2001-10-09 Medtronic Ave, Inc. One step lubricious coating
DE60130032D1 (de) * 2000-12-22 2007-09-27 Avantec Vascular Corp Vorrichtung zur Abgabe von therapeutischen Wirkstoffen
MXPA03009727A (es) * 2001-04-26 2004-01-29 Control Delivery Sys Inc SISTEMA DE SUMINISTRO DE FaRMACOS DE LIBERACIoN PROLONGADA QUE CONTIENE COFARMACOS.

Also Published As

Publication number Publication date
WO2004045549A3 (en) 2004-11-04
DK1572154T3 (da) 2012-05-14
CN1735404A (zh) 2006-02-15
ES2377827T3 (es) 2012-04-02
WO2004045549A2 (en) 2004-06-03
JP2006506191A (ja) 2006-02-23
JP4987232B2 (ja) 2012-07-25
AU2003295635A1 (en) 2004-06-15
EP1572154A4 (de) 2008-04-16
EP1572154A2 (de) 2005-09-14
CA2506319C (en) 2012-08-28
CA2506319A1 (en) 2004-06-03
KR20050086736A (ko) 2005-08-30
EP1572154B1 (de) 2012-02-01

Similar Documents

Publication Publication Date Title
ATE543488T1 (de) Medizinische vorrichtungen, bei denen neuepolymere verwendet werden
ATE483493T1 (de) Medizinische vorrichtung
ATE456935T1 (de) Ballonkatheter mit ultraschallmikroskalpellklingen
WO2004000389A3 (en) Rapidly dissolving micro-perforator for drug delivery and other applications
ATE478656T1 (de) Biologisch abbaubare polymerzusammensetzungen, zusammensetzungen und damit in beziehung stehende verwendungen
DK0774005T3 (da) Overfladeudtrykkelse af enzymer i genorienteret prodrug-terapi
CL2003002277A1 (es) Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente.
DK1061900T3 (da) Dermale præparater
DK0759747T3 (da) Transdermal indretning til administration gennem de-epitheliseret hud
EP2977043A3 (de) Eindringender pharmazeutischer schaum
CY1107752T1 (el) Xρηση των εξενδινων και αγωνιστων τους για τη θεραπεια του σακχαρωδους διαβητη της κυησης
ATE516838T1 (de) Medizinische vorrichtung mit schubkraftbegrenzung
WO2003061593A3 (en) Novel targeted compositions for diagnostic and therapeutic use
BR0008940A (pt) Artigos absorventes com lêndeas e partìculas de fluxo livre
ATE306254T1 (de) Zubereitungen mit verbesserter kontrollierter freisetzung
ATE394148T1 (de) Socke
DE69824600D1 (de) Minimal-invasive anzeige-vorrichtung
ATE344049T1 (de) Medikament, enthaltend cyanidin-3-glykosid als wirkstoff gegen fettsucht und diabetes
FI96870C (fi) Vedettömiä ihonpuhdistusaineita ja niiden käyttö
BR0100564A (pt) Estrutura compósita com matriz adesiva,contendo um ou vários ativos
AR038355A1 (es) Preparacion liofilizada que comprende inmunocitoquinas
ES2172485T1 (es) Composiciones oftalmicas en forma de gel acuoso.
NO20032791L (no) Et fleksibelt beskyttelseslag for produkter som skal beskytte legemet
ES2199094T1 (es) Polimeros formadores de pelicula, procedimientos de uso y aplicaciones de los mismos.
ES2180515T3 (es) Dispositivo de rotura controlada de una estructura que trabaja a traccion y equipo que aplica el mismo.